Core Viewpoint - Zhendemedical (603301) announced a profit forecast for 2024, expecting a net profit between 373 million to 393 million yuan, representing a year-on-year growth of 88.00% to 98.09% [1] Group 1: Company Performance - The stock price of Zhendemedical closed at 21.44 yuan, with a slight increase of 0.28% on the announcement day [1] - The trading volume was 23.23 million yuan, with a turnover rate of 0.41% [1] - Over the past five days, the stock has increased by 2.10% [1] Group 2: Market Reaction - A statistical analysis showed that 72.26% of stocks with a profit forecast increase of over 50% experienced a price increase on the announcement day [1] - Among these stocks, 20 companies hit the daily price limit on the announcement day [1] - Over the following five days, 83.87% of these stocks saw price increases [1] Group 3: Capital Flow - On the announcement day, Zhendemedical experienced a net inflow of 370,900 yuan in main funds, while there was a net outflow of 238,900 yuan over the past five days [1] - As of January 20, the margin balance was 36.91 million yuan, with a financing balance of 36.64 million yuan, reflecting a 0.86% increase from the previous trading day [1] - The financing balance has decreased by 3.30% over the past five days [1]
振德医疗发布2024年预增公告 净利润同比增长88.00%~98.09%